Livestrong Cancer Institutes' Patient Reported Outcomes Study
NCT04627077 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 121
Last updated 2020-11-13
Summary
The goal of this study will be to collect baseline patient reported outcome measures at the Livestrong Cancer Institutes (LCI) with the goal of improving quality care and to inform decision making by patients, providers, and researchers for future LCI initiatives.
Conditions
- Neoplasms
- Drug Therapy
Sponsors & Collaborators
-
University of Texas at Austin
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-22
- Primary Completion
- 2019-01-25
- Completion
- 2019-01-25
Countries
- United States
Study Locations
More Related Trials
-
Effectiveness of Bronchoscopic Interventions for Malignant Airway Obstruction
NCT03326570 ·Status: COMPLETED
-
Computer-Generated Quality of Life Assessment Program for Advanced Non-Small Cell Lung Cancer Patients (LUNL2)
NCT01337102 ·Status: COMPLETED ·Phase: NA
-
SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer
NCT02562027 ·Status: COMPLETED ·Phase: NA
-
Building a Multidisciplinary Bridge Across the Quality Chasm in Thoracic Oncology
NCT02123797 ·Status: COMPLETED
-
A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine
NCT02597738 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Patient-Defined Treatment Success and Preferences in Stage IV Lung Cancer Patients
NCT02190864 ·Status: UNKNOWN
-
Developing Circulating and Imaging Biomarkers Towards Personalised Radiotherapy in Lung Cancer
NCT06086574 ·Status: RECRUITING
-
Molecular Profiling in Small Cell Lung Cancer
NCT03162705 ·Status: UNKNOWN
-
Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer
NCT05292521 ·Status: RECRUITING ·Phase: NA
-
Implementation of Up-front ctDNA Into Lung Cancer Care and Development of Liquid Biopsy-based Decision Support Models - LM² Study
NCT06105177 ·Status: RECRUITING
-
Survival Outcomes of Lung Cancer
NCT03647098 ·Status: RECRUITING
-
Prospective Study to Determine Impact of Early Palliative Care Consult on Quality of Life (QOL), Cancer Related Symptoms In Advanced Lung Cancer Patients: Thoracic Pilot Project
NCT02459002 ·Status: COMPLETED
-
Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers
NCT00716209 ·Status: UNKNOWN
-
Prospective Clinicogenomic Program
NCT04180176 ·Status: COMPLETED ·Phase: PHASE4
-
Patient Reported Outcome Measures (PROMs) With Trabectedin
NCT03959033 ·Status: TERMINATED
-
Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer
NCT02117440 ·Status: TERMINATED
-
Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer
NCT03563976 ·Status: RECRUITING
-
Integrative Analysis of Large-cell Lung Cancer
NCT02917369 ·Status: RECRUITING
-
Maximizing Benefit of Lung Cancer Screening Incidental Findings of Cardiovascular, Respiratory and Breast Measures
NCT05900544 ·Status: WITHDRAWN ·Phase: NA
-
A Translational Study Investigating PD-L1 Expression After Radiotherapy for Non-small Cell Lung Cancer
NCT03258788 ·Status: COMPLETED
-
Detection of Circulating Tumor DNA After Stereotactic Ablative Radiotherapy in Patients With Unbiopsied Lung Tumors
NCT05921474 ·Status: UNKNOWN
-
Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy
NCT06869239 ·Status: RECRUITING
-
Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting
NCT05826756 ·Status: RECRUITING
-
Non-small Cell Lung Cancer and Quality of Life
NCT00818402 ·Status: COMPLETED
-
Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants
NCT00899457 ·Status: COMPLETED